CDC: ILI activity continues to pick up FDA approves Savaysa tabs from Daiichi Sankyo Impax Pharmaceuticals launches treatment for Parkinson's disease Researchers are developing inhalable vaccines targeting lung-specific diseases Walgreens Flu Index: Flu continues to rage across the South Keryx Biopharmaceuticals begins shipping treatment for patients with chronic kidney disease on dialysis CDC: ILI rates reach 5.9% FDA approves Saxenda from Novo Nordisk Actavis, Adamas approved for Namzaric FDA approves sBLA for Genentech's Gazyva First Previous 146 147 148 149 150 Next Last
